PING supported by:
w4ulogo               hertslogo               Watford Chamber logo      
administered by:
w4ulogo
  • About PING
  • News
    • Off-Patent Drugs Bill does not make progress in Parliament
  • Press
  • Links
  • Contact PING

Martha Lane Fox advocates GPs to urge patients to book online

By Paul Gershlick On 23/12/2015 · Leave a Comment

Patients should be urged by GPs to book their appointments, request repeat prescriptions and access their medical records online. That is one of four recommendations made by Martha Lane Fox, the Internet entrepreneur famous for her role in lastminute.com, to the UK Government in the take-up of digital opportunities in healthcare. The other three recommendations […]

Continue Reading →

High Court injunction prevents sale of full label pregabalin

By Tom Cahill On 02/12/2015 · Leave a Comment

Warner-Lambert v Sandoz and Lloyds Pharmacy, High Court

The High Court has granted interim injunctions preventing Sandoz from trading in full label generic pregabalin and Lloyds Pharmacy from dispensing such product.

Background

The case concerns the pharmaceutical product, pregabalin, marketed by Pfizer under the brand name, Lyrica. Warner-Lambert, which is part of the Pfizer group, […]

Continue Reading →

Pfizer takes over Allergan to make world’s biggest pharma company

By Paul Gershlick On 25/11/2015 · Leave a Comment

Pfizer and Allergan have agreed to join together to form the world’s biggest pharma company. Pfizer is paying US$160,000 for the company best known for its Botox products. The new entity will be known as Pfizer. The friendly deal will see Pfizer’s Ian Read as chief executive and chairman, and Allergan’s Brent Saunders as president […]

Continue Reading →

European SPC waiver proposed to promote pharmaceutical manufacturing

By Tom Cahill On 23/11/2015 · Leave a Comment

The European Commission has put forward plans for a waiver of supplementary protection certificates (SPCs) to stimulate pharmaceutical manufacturing in Europe. The proposal would remove obstacles to the competitiveness of EU industry by allowing the manufacture for export of generics and biosimilars, which are protected by SPCs in Europe, but not in the non-EU country […]

Continue Reading →
← Previous Entries Next Entries →
  • Newsletter

    Click here to subscribe to our newsletters for Pharma and Healthcare

PING

  • Website Terms of Use
  • Privacy and Cookies Policy

Sitemap | Accessibility | Disclaimer | Cookie Policy | Data Protection | Regulatory matters

Click here to give us feed back. Feel free to join the discussion by leaving comments, and stay updated by subscribing to the RSS feed. © 2016 PING

© Veale Wasbrough Vizards LLP. All rights reserved. Veale Wasbrough Vizards LLP is a limited liability partnership registered in England and Wales, registered number OC384033, registered office Narrow Quay House, Narrow Quay, Bristol, BS1 4QA. A list of members may be inspected at the registered office. The term Partner means a member of Veale Wasbrough Vizards LLP or a senior employee of equivalent standing. Veale Wasbrough Vizards LLP is authorised and regulated by the Solicitors Regulation Authority (SRA 597329) A member of The Association of European Lawyers with representative offices throughout the EU & Central & Eastern Europe. VAT Registration number GB 172 8860 77.